ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 41 filers reported holding ACORDA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $6,088,000 | -58.8% | 7,114,000 | -57.2% | 0.11% | -59.3% |
| Q1 2019 | $14,762,000 | +36.4% | 16,632,000 | +27.9% | 0.28% | +182.8% |
| Q4 2018 | $10,820,000 | +112.4% | 13,000,000 | +116.7% | 0.10% | +43.5% |
| Q3 2018 | $5,094,000 | -65.6% | 6,000,000 | -60.6% | 0.07% | -66.7% |
| Q2 2018 | $14,796,000 | +24.7% | 15,230,000 | +17.3% | 0.21% | +10.1% |
| Q1 2018 | $11,866,000 | +1.0% | 12,985,000 | -5.8% | 0.19% | +2.2% |
| Q4 2017 | $11,743,000 | -17.2% | 13,785,000 | -12.1% | 0.18% | -13.2% |
| Q3 2017 | $14,176,000 | +135.4% | 15,690,000 | +124.1% | 0.21% | +116.3% |
| Q2 2017 | $6,021,000 | -81.2% | 7,000,000 | -81.3% | 0.10% | -78.9% |
| Q1 2017 | $31,980,000 | -24.9% | 37,450,000 | +1.5% | 0.46% | -17.3% |
| Q4 2015 | $42,596,000 | – | 36,900,000 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYMPHONY ASSET MANAGEMENT LLC | 23,872,000 | $18,748,000 | 4.04% |
| PFM Health Sciences, LP | 49,764,825 | $39,319,000 | 1.16% |
| Partner Investment Management, L.P. | 659,175 | $521,000 | 0.89% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 40,000,000 | $31,402,000,000 | 0.87% |
| Bruce & Co., Inc. | 6,000,000 | $4,200,000 | 0.87% |
| CANYON CAPITAL ADVISORS LLC | 36,500,000 | $28,747,000 | 0.62% |
| PenderFund Capital Management Ltd. | 2,000,000 | $1,571,000 | 0.53% |
| Shaolin Capital Management LLC | 4,000,000 | $3,136,000 | 0.48% |
| Castle Creek Arbitrage, LLC | 2,310,000 | $1,815,000 | 0.46% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,500,000 | $4,368,000 | 0.27% |